Explore more publications!
Wellness Wire Kansas
Submit Press Release

Wellness Wire Kansas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Wire Kansas.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 2, 2025

Vireo Growth Inc. Enters into Definitive Agreements to Acquire Outstanding Senior Secured Convertible Notes of Schwazze
October 2, 2025

Vireo Growth Inc. Enters into Definitive Agreements to Acquire Outstanding Senior Secured Convertible Notes of Schwazze

Indeterminate GlobeNewswire
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
October 2, 2025

XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.

Indeterminate GlobeNewswire
BEYOND IMMORTALITY: European Wellness Biomedical Group Unveils Landmark Research on Longevity Through Cell Regeneration Over Organ Transplants
October 2, 2025

BEYOND IMMORTALITY: European Wellness Biomedical Group Unveils Landmark Research on Longevity Through Cell Regeneration Over Organ Transplants

Indeterminate GlobeNewswire
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2025

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Cardiff Oncology to Participate in Two Upcoming Investor Conferences
October 2, 2025

Cardiff Oncology to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
October 2, 2025

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences
October 2, 2025

Tenaya Therapeutics to Participate in Upcoming October Investor Conferences

Indeterminate GlobeNewswire
Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction
October 2, 2025

Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction

Indeterminate GlobeNewswire
Dyne Therapeutics Appoints Brian Posner to its Board of Directors
October 2, 2025

Dyne Therapeutics Appoints Brian Posner to its Board of Directors

Indeterminate GlobeNewswire
Palisade Bio Announces Closing of Upsized $138 Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option
October 2, 2025

Palisade Bio Announces Closing of Upsized $138 Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option

Indeterminate GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2025

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2025

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
October 2, 2025

Achieve Life Sciences Announces Granting of New Hire Inducement Awards

Indeterminate GlobeNewswire
Corvus Pharmaceuticals Appoints David Moore to Board of Directors
October 2, 2025

Corvus Pharmaceuticals Appoints David Moore to Board of Directors

Indeterminate GlobeNewswire
Cidara Therapeutics Announces BARDA Award to Support Expanded Manufacturing and Clinical Development of CD388, its Non-Vaccine Influenza Preventative Therapeutic
October 2, 2025

Cidara Therapeutics Announces BARDA Award to Support Expanded Manufacturing and Clinical Development of CD388, its Non-Vaccine Influenza Preventative Therapeutic

Indeterminate GlobeNewswire
Oxford Treatment Center Brings Flexible Addiction Care to Southaven, Debuts Evening IOP with Public Meet-and-Greet
October 2, 2025

Oxford Treatment Center Brings Flexible Addiction Care to Southaven, Debuts Evening IOP with Public Meet-and-Greet

Indeterminate GlobeNewswire
Edge AI Market to Grow at 36.9% CAGR Through 2030
October 2, 2025

Edge AI Market to Grow at 36.9% CAGR Through 2030

Indeterminate GlobeNewswire
UPDATE — Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys
October 2, 2025

UPDATE — Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys

Indeterminate GlobeNewswire
Cross Canada VW Van Tour Will Raise Awareness For Importance Of Natural Health Products
October 2, 2025

Cross Canada VW Van Tour Will Raise Awareness For Importance Of Natural Health Products

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions